NCT06667531

Brief Summary

Objectives:To determine which combination of abutment height and timing of placement is most effective in reducing marginal bone loss (MBL). Materials and Methods: 54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery1), group 2 (height 2; surgery1), group 3 (height 1.5; surgery1), group 4 (height 3; surgery2), group 5 (height 2; surgery2), group 6 (height 1.5; surgery2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant surgery, crown placement (T1), and at 3 (T2), 6 (T3), and 12 months after loading (T4). Partial and total MBL were compared among the treatment groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 31, 2024

Completed
Last Updated

October 31, 2024

Status Verified

October 1, 2024

Enrollment Period

1.9 years

First QC Date

October 27, 2024

Last Update Submit

October 29, 2024

Conditions

Keywords

marginal bone lossabutment heightabutment placement timing

Outcome Measures

Primary Outcomes (1)

  • Marginal bone loss (MBL) measured in mm (mm) 12 months after loading the implant.

    Cumulative MBL after 12 months of prosthetic loading measured in millimeters.

    12 months

Secondary Outcomes (1)

  • Evolution over time of marginal bone loss (MBL) measured in millimeters (mm) at different stages.

    0, 3, 6, 12 months.

Study Arms (6)

Group 1 (height 3; surgery 1)

ACTIVE COMPARATOR

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.

Procedure: Implant

Group 2 (height 2; surgery 1)

ACTIVE COMPARATOR

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.

Procedure: Implant

Group 3 (height 1.5; surgery 1)

ACTIVE COMPARATOR

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.

Procedure: Implant

Group 4 (height 3; surgery 2)

ACTIVE COMPARATOR

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.

Procedure: Implant

Group 5 (height 2; surgery 2)

ACTIVE COMPARATOR

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.

Procedure: Implant

Group 6 (height 1.5; surgery 2)

ACTIVE COMPARATOR

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.

Procedure: Implant

Interventions

ImplantPROCEDURE

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.

Also known as: Oral Surgery
Group 1 (height 3; surgery 1)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults.
  • Plaque and bleeding indices below 10%.
  • Absence of chronic periodontal diseases (periodontitis) or acute periodontal diseases (periodontal abscess).
  • Presence of intact alveolar walls.
  • Sufficient bone height and width.
  • Need for restoration of a tooth in the posterior maxillary or mandibular region (premolars and molars).
  • Incorporation into a periodontal maintenance program.

You may not qualify if:

  • History of systemic disease or radiotherapy contraindicating bone surgery.
  • Pregnant or breastfeeding women.
  • Smokers of more than 10 cigarettes per day.
  • Parafunctional habits.
  • Alcohol or drug abuse.
  • Narrow interproximal spaces (less than 9 mm).
  • Placement of implants flapless or post-extraction.
  • Insertion torque during implant placement below 35 Ncm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Salamanca

Salamanca, Salamanca, 37008, Spain

Location

Related Publications (1)

  • Quintas-Hijos J, Perez-Pevida E. Influence of intermediate abutment height and timing of placement on marginal bone loss in single implant-supported crowns: a 12-month follow-up randomized clinical trial. Clin Oral Investig. 2025 May 8;29(6):291. doi: 10.1007/s00784-025-06364-8.

MeSH Terms

Interventions

Drug ImplantsSurgery, Oral

Intervention Hierarchy (Ancestors)

Delayed-Action PreparationsDosage FormsPharmaceutical PreparationsDentistry

Study Officials

  • Esteban Pérez Pevida, Dentistry

    University of Salamanca

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Immediately after the placement of the implant, the subject was randomly assigned to one of the six treatment groups by opening a numbered sealed envelope from a computer-generated randomization list. Consequently, the surgeon was unaware of each subject's group assignment until the implant was installed. From that point onward, based on the random assignment, the intermediate abutments of the three heights were screwed with a torque lower than the implant insertion torque to the internal connection either immediately during the same installation procedure (one-abutment-one-time protocol) or delayed during the second surgery procedure at 8 weeks after the installation (two-stage protocol: submerged implant).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This controlled clinical trial aims to evaluate changes in peri-implant marginal bone levels during the first year of function around platform-switched implants placed 1.5 mm subcrestally and connected to intermediate abutments of heights 1.5, 2, and 3 mm, placed immediately at the time of the first surgery or delayed at the time of the second surgery. 54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery 1), group 2 (height 2; surgery 1), group 3 (height 1.5; surgery 1), group 4 (height 3; surgery 2), group 5 (height 2; surgery 2), group 6 (height 1.5; surgery 2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

October 27, 2024

First Posted

October 31, 2024

Study Start

June 15, 2022

Primary Completion

May 1, 2024

Study Completion

June 28, 2024

Last Updated

October 31, 2024

Record last verified: 2024-10

Locations